Travere Therapeutics (TVTX)
Develops and sells rare kidney-disease medicines led by FILSPARI.
$59.85
After hours−0.43 (−0.71%)
At close$60.28(−4.10%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
$0.03
Revenue estimate
$195.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported−$0.73−$0.47−$0.14$0.28$0.03−$0.39−$0.37Pending
Estimate−$0.58−$0.55−$0.28−$0.31$0.03−$0.30−$0.13$0.03
Surprise−25.9%+14.5%+50.0%+190.3%0.0%−30.0%−174.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$74.8M$81.7M$114.4M$164.9M$129.7M$127.2M$169.6MPending
Estimate$72.4M$88.8M$99.5M$147.0M$144.6M$136.2M$157.3M$195.7M
Surprise+3.3%−8.0%+15.0%+12.2%−10.3%−6.6%+7.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.08 | — | — |
| Sep 2027 | $0.93 | — | — |
| Jun 2027 | $0.80 | — | — |
| Mar 2027 | $0.63 | — | — |
| Dec 2026 | $0.50 | — | — |
| Oct 2026 | $0.03 | — | — |
| Aug 2026 | −$0.13 | −$0.37 | −174.8% |
| May 2026 | −$0.30 | −$0.39 | −30.0% |
| Feb 2026 | $0.03 | $0.03 | 0.0% |
| Oct 2025 | −$0.31 | $0.28 | +190.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.08 | — | — | $320.6M | — | — | — |
| Sep 2027 | $0.93 | — | — | $294.0M | — | — | — |
| Jun 2027 | $0.80 | — | — | $270.9M | — | — | — |
| Mar 2027 | $0.63 | — | — | $243.8M | — | — | — |
| Dec 2026 | $0.50 | — | — | $232.1M | — | — | — |
| Oct 29, 2026 | $0.03 | — | — | $195.7M | — | — | — |
| Aug 4, 2026 | −$0.13 | −$0.37 | −174.8% | $157.3M | $169.6M | +7.8% | +12.0% |
| May 4, 2026 | −$0.30 | −$0.39 | −30.0% | $136.2M | $127.2M | −6.6% | −0.2% |
| Feb 19, 2026 | $0.03 | $0.03 | 0.0% | $144.6M | $129.7M | −10.3% | +3.7% |
| Oct 30, 2025 | −$0.31 | $0.28 | +190.3% | $147.0M | $164.9M | +12.2% | +18.6% |
| Aug 6, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 6, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 29, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jul 30, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 24, 2020 | |||||||
| Oct 30, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Jul 26, 2018 | |||||||
| May 1, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 4, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 3, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 4, 2015 |